Focus: Element Biosciences is a biotechnology company specializing in genetic analysis and sequencing tools, focused on rare disease applications. The company is Series C+ stage based in San Diego, positioning it as a growth-stage innovator in molecular diagnostics.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Growing — net +5 jobs in 30d
9 jobs added vs 4 removed. Steady team buildout.
Best suited for technical specialists seeking early-stage genomics exposure with funding stability, but limited growth signals warrant scrutiny on commercialization timeline and market traction.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Element Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Element Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo